Skip to main content

    Peter Kolchinsky

    Probably the single most influential long-form writer on biotech investing, FDA policy, incentives, and innovation economics, and founder of RA Capital Management.

    #12 Biotech
    23CiteRank

    Last updated 13 Nov 2026 · Named in 12 answers across 5 engines
    Bing AI Mode starts a separate baseline. Copilot remains a separate public engine and keeps its history; changes across the switch are not like-for-like growth.

    How AI engines see them

    Recognized by 5 of 5 measured engines. Updated 2026-09-19
    • ChatGPTNamed in 2 answers

      He is a PhD virologist and investor in biotech.

    • GeminiNamed in 1 answers

      He is a prominent biotechnology scientist, investor, author, and advocate.

    • Google AI ModeNamed in 5 answers

      He is a biotech investor, author, and reform advocate.

    • PerplexityNamed in 1 answers

      He is one of biotech’s most influential investor-operators and public intellectuals.

    • Bing AI ModeNot named

      No description yet.

    • CopilotNamed in 3 answers

      He is a biotech investor, scientist, and policy advocate.

    Top Segments

    • #12Biotechof 66
      Named in 27 answers

    Top URLs

    1. 1
      Top 20 Biotech Voices to Follow in 2026 | Jack Shuang Hou posted on the topic | LinkedIn
      linkedin.com10 citations
    2. 2
      Profiles of Global Pharmaceutical Industry Leaders | IntuitionLabs
      intuitionlabs.ai4 citations
    3. 3
      Biotech Hangout
      biotechhangout.com3 citations

    Prompts where Peter is named

    Run now opens the answer page for that prompt.

    • Who are the most influential voices in Biotech & techbio?

      Named by 2 engines

    Track Peter

    Follow Peter's measured AI visibility and see the questions where they rank.